TNM Staging | Groups | # Samples (Cases/Control) | Platform | Genes | DEGs (UR/DR) |
---|---|---|---|---|---|
Stage I | GSE35602 | 13 (5/8) | GPL6480 | 41,108 | 3635 (2629/1006) |
GSE41258 | 81 (27/54) | GPL96 | 22,283 | 924 (366/558) | |
GSE89076 | 42 (8/34) | GPL16699 | 62,976 | 4953 (2649/2304) | |
GSE117606 | 74 (15/59) | GPL25373 | 19,276 | 424 (156/268) | |
GSE71187 | 25 (13/12) | GPL6480 | 41,108 | 3784 (1535/2249) | |
TCGA-COAD | 125 (84/41) | Illumina | 56,499 | 4520 (1631/2889) | |
TCGA-READ | 41 (31/10) | Illumina | 56,493 | 4918 (1640/3278) | |
Stage II | GSE35602 | 16 (8/8) | GPL6480 | 41,108 | 4427 (2542/1885) |
GSE41258 | 103 (49/54) | GPL96 | 22,283 | 808 (281/527) | |
GSE89076 | 42 (8/34) | GPL16699 | 62,976 | 4606 (2596/2010) | |
GSE117606 | 72 (23/59) | GPL25373 | 19,276 | 562 (232/329) | |
GSE71187 | 29 (17/12) | GPL6480 | 41,108 | 3656 (1384/2272) | |
TCGA-COAD | 132 (191/41) | Illumina | 56,499 | 4660 (1684/2976) | |
TCGA-READ | 64 (54/10) | Illumina | 56,493 | 4694 (1580/3114) | |
Stage III | GSE35602 | 18 (10/8) | GPL6480 | 54,675 | 2918 (2047/871) |
GSE41258 | 102 (48/54) | GPL96 | 22,283 | 800 (330/470) | |
GSE83889 | 128 (93/35) | GPL10558 | 48,107 | 1501 (922/579) | |
GSE89076 | 42 (11/34) | GPL16699 | 62,976 | 4955 (2787/2168) | |
GSE117606 | 73 (24/59) | GPL25373 | 19,276 | 477 (184/293) | |
GSE71187 | 63 (51/12) | GPL6480 | 41,108 | 3363 (1268/2095) | |
TCGA-COAD | 176 (135/41) | Illumina | 56,499 | 4562 (1614/2948) | |
TCGA-READ | 64 (54/10) | Illumina | 56,493 | 4863 (1763/3100) | |
Stage IV | GSE41258 | 109 (55/54) | GPL96 | 22,283 | 796 (297/499) |
GSE89076 | 38 (6/34) | GPL16699 | 62,976 | 4798 (2460/2338) | |
GSE71187 | 18 (6/12) | GPL6480 | 41,108 | 4584 (1803/2781) | |
GSE49355 | 36 (20/16) | GPL96 | 22,283 | 814 (357/457) | |
TCGA-COAD | 109 (68/41) | Illumina | 56,499 | 4619 (1657/2962) | |
TCGA-READ | 35 (25/10) | Illumina | 56,493 | 4568 (1844/2724) |